Login / Signup

Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec's Reference Center.

Simon LeclercKarim BenkiraneAnnie-Claire Nadeau-FredetteNaoual ElftouhJean-Philippe LafranceVincent PichetteVirginie RoyalCaroline LamarcheLouis-Philippe Laurin
Published in: Canadian journal of kidney health and disease (2021)
Due to the retrospective nature of this study, no trial registration was performed.
Keyphrases
  • clinical trial
  • study protocol
  • high resolution
  • phase iii
  • binding protein